2012Journal of Gannan Medical UniversityRequires access

Clinical Study on Montelukast Combined with Betoken to Treat 60 Patients with Cough Variant Asthma in Children

Luo Shou-jun

Open publisher page 0 citations

Abstract

Objective: To study the efficacy of montelukast combined with Ketotifen on the prevention of cough variant Asthma in children.Methods: 60 patients were treated with Ketotifen and montelukast sodium chewable tablets.Another 60 Patients who were taken Ketotifen orally served as control.After symptoms disappearing,Ketotifen treatment was ceased in both groups and montelukast administration continued till 2 months.Recurrence of cough,asthma conversion and adverse events had been followed up for 1 year.Results: The therapeutic efficacy in the treatment group was significantly higher than that in the control group(P 0.05).The recurrent rate of cough asthma conversion and adverse events were less in the treatment group than those in the control group(P 0.05).Conclusion: Montelukast combined with Ketotifen has better effect on cough variant asthma with little side effect in children.It is worthy of clinical promotion.

About this research paper

What this paper is about

Objective: To study the efficacy of montelukast combined with Ketotifen on the prevention of cough variant Asthma in children.Methods: 60 patients were treated with Ketotifen and montelukast sodium chewable tablets.Another 60 Patients who were taken Ketotifen orally served as control.After symptoms disappearing,Ketotifen treatment was ceased in both groups and montelukast administration continued till 2 months.Recurrence of cough,asthma conversion and adverse events had been followed up for 1 year.Results: The therapeutic efficacy in the treatment group was significantly higher than that in the control group(P 0.05).The recurrent rate of cough asthma conversion and adverse events were less in the treatment group than those in the control group(P 0.05).Conclusion: Montelukast combined with Ketotifen has better effect on cough variant asthma with little side effect in children.It is worthy of clinical promotion.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To study the efficacy of montelukast combined with Ketotifen on the prevention of cough variant Asthma in children.Methods: 60 patients were treated with Ketotifen and montelukast sodium chewable tablets.Another 60 Patients who were taken Ketotifen orally served as control.After symptoms disappearing,Ketotifen treatment was ceased in both groups and montelukast administration continued till 2 months.Recurrence of cough,asthma conversion and adverse events had been followed up for 1 year.Results: The therapeutic efficacy in the treatment group was significantly higher than that in the control group(P 0.05).The recurrent rate of cough asthma conversion and adverse events were less in the treatment group than those in the control group(P 0.05).Conclusion: Montelukast combined with Ketotifen has better effect on cough variant asthma with little side effect in children.It is worthy of clinical promotion.

Key concepts: Ketotifen, Medicine, Montelukast, Asthma, Adverse effect, Anesthesia, Clinical efficacy, Side effect (computer science)

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Study on Montelukast Combined with Betoken to Treat 60 Patients with Cough Variant Asthma in Children — Research Paper | ScholarLens